Nucleic Acids as a Nature-Inspired Scaffold for Macromolecular Prodrugs of Nucleoside Analogues.

antivirals herpes simplex virus nucleic acids nucleoside analogues prodrugs

Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
20 Mar 2019
Historique:
received: 20 11 2018
revised: 04 01 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 3 4 2019
Statut: epublish

Résumé

Macromolecular prodrugs (MP) built on the natural phosphodiester and deoxyribose backbone are developed using marketed antiviral nucleoside analogues. These MP are synthesized using automated synthesis, have defined molecular composition, and have a natural mechanism for drug release. These unique attributes, coupled to the efficient cell entry and potent antiviral effects, position the prodrugs scaffolded on nucleic acids favorably for translational studies.

Identifiants

pubmed: 30937274
doi: 10.1002/advs.201802095
pii: ADVS991
pmc: PMC6425433
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1802095

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Proc Natl Acad Sci U S A. 1989 May;86(10):3474-8
pubmed: 2726730
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6454-8
pubmed: 2549537
Science. 2006 May 19;312(5776):1027-30
pubmed: 16709779
Chem Soc Rev. 2018 Feb 21;47(4):1285-1306
pubmed: 29265140
J Clin Virol. 2003 Jan;26(1):29-37
pubmed: 12589832
Adv Drug Deliv Rev. 2013 Jan;65(1):60-70
pubmed: 22981753
Lancet Oncol. 2002 Jul;3(7):415-24
pubmed: 12142171
Adv Healthc Mater. 2017 Dec;6(23):
pubmed: 28945945
J Control Release. 2016 Jun 28;232:143-51
pubmed: 27084489
Chem Rev. 2001 Sep;101(9):2921-90
pubmed: 11749397
Nucleosides Nucleotides. 1999 Jun-Jul;18(6-7):1729-30
pubmed: 10474257
Adv Sci (Weinh). 2019 Jan 28;6(6):1802095
pubmed: 30937274
Nat Rev Drug Discov. 2017 Jun;16(6):387-399
pubmed: 28337020
Science. 2014 Oct 3;346(6205):1247390
pubmed: 25278614
Adv Healthc Mater. 2016 Mar 9;5(5):534-40
pubmed: 26789641
Clin Microbiol Rev. 2016 Jul;29(3):695-747
pubmed: 27281742
Chem Commun (Camb). 2016 Jan 18;52(5):889-91
pubmed: 26576493
J Biol Stand. 1986 Jul;14(3):201-11
pubmed: 3020058
Future Oncol. 2016 Sep;12(17):2009-20
pubmed: 27279153
Nature. 2014 Mar 27;507(7493):519-22
pubmed: 24531764
Chem Asian J. 2013 Aug;8(8):1634-44
pubmed: 23606667
Clin Microbiol Rev. 2003 Jan;16(1):114-28
pubmed: 12525428
J Am Chem Soc. 2012 Jan 25;134(3):1376-91
pubmed: 22229439
Nat Nanotechnol. 2011 Nov 06;6(12):763-72
pubmed: 22056726
Antimicrob Agents Chemother. 2011 Feb;55(2):459-72
pubmed: 21078929
Antimicrob Agents Chemother. 2006 Apr;50(4):1393-401
pubmed: 16569857
Nat Rev Drug Discov. 2003 May;2(5):347-60
pubmed: 12750738

Auteurs

Franziska Krüger (F)

Institute of Molecular Virology Ulm University Medical Center 89081 Ulm Germany.

Vipin Kumar (V)

Department of Chemistry and iNano Interdisciplinary Nanoscience Centre Aarhus University Aarhus C 8000 Denmark.

Pere Monge (P)

Department of Chemistry and iNano Interdisciplinary Nanoscience Centre Aarhus University Aarhus C 8000 Denmark.

Carina Conzelmann (C)

Institute of Molecular Virology Ulm University Medical Center 89081 Ulm Germany.

Nikaïa Smith (N)

Institute of Molecular Virology Ulm University Medical Center 89081 Ulm Germany.

Kurt V Gothelf (KV)

Department of Chemistry and iNano Interdisciplinary Nanoscience Centre Aarhus University Aarhus C 8000 Denmark.

Martin Tolstrup (M)

Aarhus University Hospital Aarhus N 8200 Denmark.

Jan Münch (J)

Institute of Molecular Virology Ulm University Medical Center 89081 Ulm Germany.

Alexander N Zelikin (AN)

Department of Chemistry and iNano Interdisciplinary Nanoscience Centre Aarhus University Aarhus C 8000 Denmark.

Classifications MeSH